Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2014-12-03 17:00:37
Reporting Period:
Filing Date:
Accepted Time:
2014-12-03 17:00:37
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1208261 Immune Pharmaceuticals Inc IMNP Pharmaceutical Preparations (2834) 521841431
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1421882 Cameron Durrant Cambridge Innovation Center
One Broadway, 14Th Floor
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-26 4,000 $2.50 4,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant Acquisiton 2014-11-26 1,000 $0.00 1,000 $3.75
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,000 2014-11-26 2017-11-26 No 4 P Direct
  1. The securities were purchased by the Reporting Person in connection with the underwriter's partial exercise of its over-allotment option to purchase additional units in the Issuer's underwritten public offering that closed on November 25, 2014.